Products

CAT # Product Name Description
CPDP803942 N-[4-[(1S,3R,5R)-3-Amino-5-methylcyclohexyl]-3-...
CPDM400499 1,1-Dimethylethyl N-[(1R,3S,5R)-3-(3-amino-4-py...
CPDS101826 tert-butyl ((1R,3R,5S)-3-(3-aminopyridin-4-yl)-...
CPDM400502 benzyl (4-((1R,3R,5S)-3-(benzylamino)-5-methylc...
CPDM400488 Phenylmethyl 2-(trifluoromethoxy)acetate
CPDP802610 6-(2,6-difluorophenyl)-5-fluoropicolinic acid
CPD111973 LGH-447; PIM-447 PIM447 (LGH447) is an effective, oral, and selective pan PIM kinase inhibitor.
CPDP803898 (1S)-1-(4-bromo-2-thienyl)ethylamine
CPDS101822 5-(difluoromethyl)-1,2-dihydro-3H-pyrazol-3-one
CPDM400498 tert-butyl 4-(4-amino-3-ethylphenyl)piperazine-...
CPDM400497 tert-butyl 4-(4-nitro-3-vinylphenyl)piperazine-...
CPDM400496 tert-butyl 4-(3-bromo-4-nitrophenyl)piperazine-...
CPDM400495 2-(difluoromethyl)-3-iodo-6,7-dihydro-5H-pyrazo...
CPDM400494 2-(difluoromethyl)-6,7-dihydro-5H-pyrazolo[5,1-...
CPDM400493 4-bromo-3-(difluoromethoxy)-1-methyl-1H-pyrazole
CPDM400492 4-bromo-1-methyl-1,2-dihydro-3H-pyrazol-3-one
CPDM400483 (1S,2R)-4-bromo-2-fluoro-1-(methoxymethoxy)-7-(...
CPDM400468 (S)-tert-butyl 3-((9-ethyl-2-fluoro-9H-purin-6-...
CPDM400447 6-Bromo-2-hydroxy-3-methylquinoline-4-carboxyli...
CPDM400467 tert-butyl 5-amino-4-(2-chlorophenyl)pentanoate...
CPDP803749 5-(tert-butyl) 2-ethyl 4,6-dihydropyrrolo[3,4-d...
CPD109347 (S)-JDQ-443 (S)-Opnurasib ((S)-JDQ-443; (S)-NVP-JDQ443) is an isomer of Opnurasib (HY-139612).
CPD113103 1-((1S,2S)-2-aminocyclohexyl)-3-(3,5-bis(triflu...
CPDM400265 2-(2-Chloro-6-(1,3-dioxolan-2-yl)-5-fluoro-3-me...
CPDM400057 Methyl 4-iodo-2-methyl-3-nitrobenzoate
CPDM400457 3-bromo-5-methylpyrazin-2-amine
CPDM400368 1-(oxetan-3-yl)piperazine 2,2,2-trifluoroacetate
CPDP803701 (S)-2-chloro-4-(6-(hydroxymethyl)-6-methyl-4-ox...
CPDM400454 4-bromo-N-ethyl-6,7-dihydro-6-methyl-7-oxo-1H-P...
CPD109670 28-Noroleana-1,9(11)-diene-2-carbonitrile, 17-a...

Contact Us

Inquiry

Latest News

  • Top 7 Trends In Pharmaceutical Research In 2018

    Top 7 Trends In Pharmaceutical Research I...

      Being under ever-increasing pressure to compete in a challenging economic and technological environment, pharmaceutical and biotech companies must continually innovate in their R&D programmes to stay ahead ...

  • ARS-1620: A promising new inhibitor for KRAS-mutant cancers

    ARS-1620: A promising new inhibitor for K...

    According to a study published in Cell, researchers have developed a specific inhibitor for KRASG12C called ARS-1602 that induced tumor regression in mice. “This study provides in vivo evidence that mutant KRAS can be...

  • AstraZeneca receives regulatory boost for oncology drugs

    AstraZeneca receives regulatory boost for...

    AstraZeneca received a double boost for its oncology portfolio on Tuesday, after US and European regulators accepted regulatory submissions for its drugs, the first step towards winning approval for these medicines. ...

WhatsApp Online Chat !